Commitments and Contingencies (Tables)

6 Months Ended

12 Months Ended

Dec. 31, 2015

Jun. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments And Contingencies Disclosure [Table Text Block]

Commitments and contingencies are described below and summarized by the following table for the designated fiscal years ending June 30, as of December 31, 2015:

	Total		Remaining 2016		2017		2018		2019		2020		Thereafter

Management fee	$	1,620,000	$	180,000	$	360,000	$	360,000	$	360,000	$	360,000	$	-
Primsol business		1,250,000		1,000,000		250,000		-		-		-		-
Manufacturing agreement		1,000,000		1,000,000		-		-		-		-		-
Office Lease		385,000		68,000		142,000		145,000		30,000		-		-
Sponsored research agreement with related party		315,000		35,000		70,000		70,000		70,000		70,000		-
	$	4,570,000	$	2,283,000	$	822,000	$	575,000	$	460,000	$	430,000	$	-

Commitments and contingencies are described below and summarized by the following table as of June 30, 2015:

	Total		2016		2017		2018		2019		2020		Thereafter

Management fee	$	1,800,000	$	360,000	$	360,000	$	360,000	$	360,000	$	360,000	$	—
ProstaScint Inventory Transfer		500,000		500,000		—		—		—		—		—
Sponsored research agreement with related party		350,000		70,000		70,000		70,000		70,000		70,000		—
Clinical research and trial obligations		329,000		329,000		—		—		—		—		—
Manufacturing		133,000		133,000		—		—		—		—		—
Office Lease		110,000		35,000		36,000		36,000		3,000		—		—
	$	3,222,000	$	1,427,000	$	466,000	$	466,000	$	433,000	$	430,000	$	—

Schedule of Rent Expense [Table Text Block]

Rent expense for the respective periods is as follows:

	Three Months Ended December 31,				Six Months Ended December 31,
	2015		2014		2015		2014

Rent expense	$	34,000	$	22,000	$	51,000	$	40,000

Rent expense for the respective periods is as follows:

	Years Ended June 30,
	2015		2014

Rent expense	$	51,000	$	11,000